Guobang Pharma Ltd (605507) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.038x

Based on the latest financial reports, Guobang Pharma Ltd (605507) has a cash flow conversion efficiency ratio of 0.038x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥311.27 Million ≈ $45.55 Million USD) by net assets (CN¥8.28 Billion ≈ $1.21 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Guobang Pharma Ltd - Cash Flow Conversion Efficiency Trend (2017–2024)

This chart illustrates how Guobang Pharma Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 605507 current and long-term liabilities for a breakdown of total debt and financial obligations.

Guobang Pharma Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Guobang Pharma Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Shandong Yisheng Livestock & Poultry Breeding Co Ltd SHE:002458	0.021x
Thai President Foods Public Company Limited BK:TFMAMA	0.024x
Imax Corp NYSE:IMAX	0.066x
Agilysys Inc NASDAQ:AGYS	0.074x
J.Pond Precision Technology Co. Ltd. A SHE:301326	N/A
Innospec Inc NASDAQ:IOSP	0.030x
Sichuan Expressway Co Ltd SHG:601107	0.053x
Shanghai SK Automation Technology Co. Ltd. A SHG:688155	N/A

Annual Cash Flow Conversion Efficiency for Guobang Pharma Ltd (2017–2024)

The table below shows the annual cash flow conversion efficiency of Guobang Pharma Ltd from 2017 to 2024. For the full company profile with market capitalisation and key ratios, see Guobang Pharma Ltd market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥8.05 Billion ≈ $1.18 Billion	CN¥706.41 Million ≈ $103.37 Million	0.088x	+26.26%
2023-12-31	CN¥7.44 Billion ≈ $1.09 Billion	CN¥516.76 Million ≈ $75.62 Million	0.069x	-51.12%
2022-12-31	CN¥7.15 Billion ≈ $1.05 Billion	CN¥1.02 Billion ≈ $148.82 Million	0.142x	+611.99%
2021-12-31	CN¥6.35 Billion ≈ $928.57 Million	CN¥-176.18 Million ≈ $-25.78 Million	-0.028x	-111.84%
2020-12-31	CN¥3.27 Billion ≈ $479.11 Million	CN¥767.70 Million ≈ $112.34 Million	0.234x	+39.13%
2019-12-31	CN¥2.62 Billion ≈ $382.78 Million	CN¥440.86 Million ≈ $64.51 Million	0.169x	-19.35%
2018-12-31	CN¥2.59 Billion ≈ $379.31 Million	CN¥541.68 Million ≈ $79.27 Million	0.209x	+211.60%
2017-12-31	CN¥2.21 Billion ≈ $323.00 Million	CN¥148.03 Million ≈ $21.66 Million	0.067x	--

About Guobang Pharma Ltd

SHG:605507 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.92 Billion

CN¥13.15 Billion CNY

Market Cap Rank

#6447 Global

#1464 in China

Share Price

CN¥23.54

Change (1 day)

-1.59%

52-Week Range

CN¥19.12 - CN¥29.25

All Time High

CN¥43.71